These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941? Van Meerbeeck JP; De Pauw R; Tournoy K Expert Rev Anticancer Ther; 2008 Feb; 8(2):199-206. PubMed ID: 18279061 [TBL] [Abstract][Full Text] [Related]
8. Invited commentary. Low D Ann Thorac Surg; 2004 Nov; 78(5):1753-4. PubMed ID: 15511467 [No Abstract] [Full Text] [Related]
9. Subcategorization of resectable non-small cell lung cancer involving neighboring structures. Sakakura N; Mori S; Ishiguro F; Fukui T; Hatooka S; Shinoda M; Yokoi K; Mitsudomi T Ann Thorac Surg; 2008 Oct; 86(4):1076-83; discussion 1083. PubMed ID: 18805135 [TBL] [Abstract][Full Text] [Related]
10. [Has survival of non-small-cell lung cancer patients been ameliorated over the course of the past 20 years?]. Milleron B Rev Pneumol Clin; 2005 Sep; 61(4 Pt 2):4S31-5. PubMed ID: 16273008 [No Abstract] [Full Text] [Related]
11. Is primary resection of stage IIIA lung cancer futile? Grannis FW Ann Thorac Surg; 2008 Jul; 86(1):353-4; author reply 354. PubMed ID: 18573468 [No Abstract] [Full Text] [Related]
12. Invited commentary. Yang SC Ann Thorac Surg; 2009 Sep; 88(3):928-9. PubMed ID: 19699922 [No Abstract] [Full Text] [Related]
13. [Recommendations on the therapy of bronchial carcinoma]. Thomas M; Baumann M; Deppermann M; Freitag L; Gatzemeier U; Huber R; Passlick B; Serke M; Ukena D Pneumologie; 2002 Feb; 56(2):113-31. PubMed ID: 11842350 [No Abstract] [Full Text] [Related]